ETHYL 5-CHLORO-4-FLUORO-1H-INDOLE-2-CARBOXYLATE, 97.0%, 250mg

6-(4-Boc-Piperazino)-2-methylpyridine-3-boronic acid, 98%, 1g

Tert-butyl (2s,4r)-2-(dimethylcarbamoyl)-4-hydroxypyrrolidine-1-carboxylate, 95+%, 1g

Thieno[2,3-d]pyrimidine-2,4(1H,3H)-dione, 5-[[(4S)-4-hydroxy-4-methyl-2-isoxazolidinyl]carbonyl]-3-methyl-1-(1-methylethyl)-6-[[5-methyl-3-(trifluoromethyl)-1H-pyrazol-4-yl]methyl]-, 25mg

Tris(2-pyridylmethyl)amine>98.0%(HPLC)1g

2-Chloro-5-fluoro-3-methylbenzaldehyde, 97%, 1g

(S)-2-((((9H-Fluoren-9-yl)methoxy)carbonyl)amino)-3-(pyridin-2-yl)propanoic acid, 95.0%, 5g

7-Chloro-6-fluoro-1H-indole, 95%, 1g

Butyraldehyde>98.0%(GC)500mL

GC capillary column ROTI®Cap-1, 15 m, 0.32 mm, 1.00 µm, 1 Piece(s)

(3,5-Dimethylpyridin-2-yl)methanol, 95.0%, 5g

rel-(1R,5S,9s)-tert-Butyl 9-amino-3-azabicyclo[3.3.1]nonane-3-carboxylate, 95.0%, 1g

Areometer precision, 0,900 to 1,000 g/cm³